Table 2. BW (g), kidney/BW ratio (mg/g), heart/BW ratio (mg/g), GFR (ml/min), urinary albumin excretion (UAE, mg/24 h) in control, CsA, and CsA+C21-treated rats at the end of 28 days of treatment.
*P<0.01 compared with control group.
| Control | CsA | CsA+C21 | |
|---|---|---|---|
| BW, g | 401.42±2.02 | 368.65±8.58* | 360.66±7.52* |
| Kidney/BW, mg/g | 3.929±0.145 | 3.902±0.108 | 4.130±0.083 |
| Heart/BW, mg/g | 2.927±0.134 | 2.942±0.048 | 3.129±0.121 |
| GFR, ml/min | 2.788±0.899 | 2.040±0.290 | 2.929±0.624 |
| UAE, mg/24 h | 2.13±0.45 | 2.65±0.42 | 2.08±0.23 |